Addendum C to Management Services Agreement between Immix Biopharma, Inc. and Alwaysraise LLC (May 2023)

Contract Categories: Business Operations › Management Agreements
Summary

This addendum updates the Management Services Agreement between Immix Biopharma, Inc. and Alwaysraise LLC, originally dated March 24, 2021. The amendment specifically increases the compensation amount from $35,416 to $37,166. All other terms of the original agreement remain unchanged. The addendum is signed by representatives of both companies and is effective as of May 12, 2023.

Read More Arrow
EX-10.3 3 ex10-3.htm

 

Exhibit 10.3

 

RE: Management Services Agreement – Addendum C

May 12, 2023

 

Further to the Management Services Agreement dated March 24, 2021 (the “Agreement”) by and between Immix Biopharma, Inc. (the “Company”) and Alwaysraise LLC (“Alwaysraise”), this letter (“Addendum C”) hereby amends as follows:

 

The parties hereby amend Section 4 “Compensation” specifically as follows, and not otherwise:

 

  1. Delete “$35,416” and replace with “$37,166”.

 

All other terms and conditions of the Agreement remain in place.

 

IMMIX BIOPHARMA, INC.   ALWAYSRAISE LLC
     
By: /s/ Ilya Rachman   By: /s/ Gabriel Morris
Name: Ilya Rachman   Name: Gabriel Morris
Title: CEO, Immix Biopharma   Title:  

 

ACKNOWLEDGED AND ACCEPTED:  
   
/s/ Gabriel Morris  
Gabriel Morris